Medical Daily

The Case Against Splitting MMR: More Injections, More Visits, More Time Unprotected, and No Measured Benefit

A public health scientist argues that splitting MMR into three shots would add injections and visits with no demonstrated benefit.

Tirzepatide Was Linked to Fewer Heart Attacks in Nearly 53,000 Patients, but the Evidence Has Limits

A BMJ cohort study tied tirzepatide to a 32 percent lower risk of heart attack, stroke, or death, but it was not a randomized trial.